<DOC>
	<DOCNO>NCT02159430</DOCNO>
	<brief_summary>Since 1963 Hereditary AngioEdema ( HAE ) consider autosomal dominant disorder ( Donaldson Evans ) , characterize quantitative and/or qualitative deficit C1 esterase inhibitor ( C1-INH ) , affect approximately 1:50.000 individual general population . From period link HAE psychiatry interrupt , however genetic issue could comprehensively explain clinical evolution disease . Clinical study show evident gap genotype phenotype HAE . For still controversial question , design cross-sectional study order establish relationship HAE clinical manifestation neurobiological/psychopatological parameter .</brief_summary>
	<brief_title>Hereditary AngioEdema , Neurobiology Psychopathology</brief_title>
	<detailed_description />
	<mesh_term>Angioedema</mesh_term>
	<mesh_term>Angioedemas , Hereditary</mesh_term>
	<criteria>Diagnosis HAE Current pharmacological treatment include ACEinhibitors , ACE inhibitor , glucocorticoid , oestroprogestative , psychotropic drug , drug act immune system ( 15 day ) , anesthetic ( previous three month ) . Inflammation / infection ( eg , chronic inflammatory disease , acute ) last 15 day . Ongoing allergy . Night work past 15 day . Vigorous physical activity alcohol consumption ( day assessment ) . Women follicular phase menstrual cycle .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>